抗血栓薬の世界市場:抗凝固薬、抗血小板薬...市場調査レポートについてご紹介

【英文タイトル】Antithrombotic Drugs: World Industry and Market Prospects 2015-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1.1 Overview of the World Market for Antithrombotic Drugs
1.2 Why Should You Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by This Analysis
1.5 Who Is This Study For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain
1.10 Glossary of Abbreviations

2. Blood Clotting: Mechanisms, Disorders and Current Treatments
2.1 Understanding Haemostasis and Coagulation
2.2 What is Thrombosis
2.3 Complications of Thrombosis
2.3.1 Pulmonary Embolism: A Thrombus Blocking Blood Supply to the Lungs
2.3.2 Stroke Results From Blockage of Blood Flow to the Brain
2.3.3 Acute Coronary Syndrome (ACS): Blockage of Blood Supply to the Heart
2.4 Antithrombotic Drug Treatment

3. Antithrombotic Drugs: World Market 2015-2025
3.1 The World Antithrombotic Drug Market in 2013 and 2014
3.2 The World Antithrombotic Drug Market: Overarching Revenue Forecast 2014-2025
3.3 Driving and Restraining Forces Affecting the Antithrombotic Drugs Market
3.3.1 An Increasing Patient Population Drives Market Growth
3.3.2 Intense Competition from Generics Threatens to Restrain the Market
3.4 The Antithrombotic Drug Market by Therapeutic Class: Revenue and Market Share Predictions, 2019 and 2025
3.5 The Future of the World Market for Antithrombotic Drugs by Therapeutic Class: Grouped Revenue Forecasts, 2014-2025
3.6 Anticoagulant Drugs: Leading the Market from 2014 Onwards
3.6.1 Direct Factor Xa Inhibitors: A Novel Therapeutic Class With Great Potential
3.6.2 Heparins: Second-Leading Anticoagulant Class in 2013
3.6.3 Direct Thrombin Inhibitors Achieved High Growth in 2013 and 2014
3.6.4 Vitamin K Antagonists Have Led the Anticoagulant Drug Market for 60 Years
3.7 Antiplatelet Drugs Were the Second-Leading Therapeutic Class in 2014
3.8 Fibrinolytics Will Continue to be a Staple of the Antithrombotic Drug Market

4. Leading Products in the Market: Prospects, 2015-2025
4.1 Plavix and Lovenox Remain the Market Leaders in 2012 and 2013, Despite Generic Competition
4.2 The Leading Antithrombotic Drugs: Comparison of Revenue and Market Share, 2019 and 2025
4.3 Which Medicines Will Achieve the Highest Rate of Growth to 2025?
4.4 Plavix Faces Competition from Generics, So What Does the Future Hold?
4.4.1 Branded Competition for Plavix?
4.5 Lovenox: Biosimilar Competition in the EU is Expected
4.6 Xarelto: Leading Antithrombotic of 2014
4.7 Pradaxa’s Continued Growth in 2014
4.8 Activase Leads the Fibrinolytics Market, With Little Competition
4.9 Effient Competes with Brilinta/Brilique as well as Generic Competition for Plavix
4.10 Aspirin Cardio: The Most Lucrative Version of Acetylsalicylic Acid
4.11 Angiomax/Angiox is Losing Share of the Direct Thrombin Inhibitors Market to Pradaxa
4.12 Pletal Faces Generic Competition and Restrictions on Use in Europe
4.13 Aggrenox/Asasantin to Face Generic Competition Earlier Than Expected in the US
4.14 Sandoz’s Enoxaparin Sodium: Revenue Forecast 2014-2025
4.15 Fragmin Faces Rivalry from Generic Competition to Lovenox
4.16 Brilinta/Brilique: Investigation Closed in 2014
4.17 Eliquis: Will Late Entry to the Market Affect Uptake?
4.18 Arixtra: Aspen Pharmacare Has Acquired Worldwide Rights from GSK
4.19 New Approvals in the Antithrombotic Drugs Market, 2014
4.19.1 Zontivity: The Newest Approval in Antithrombotics
4.19.2 Lixiana/Savaysa: Expansion into Other Regional Markets

5. Leading National Markets, 2014-2025
5.1 Which Were the Leading National Markets for Sales of Antithrombotic Drugs in 2013 and 2014?
5.2 The Leading National Markets for Antithrombotic Drugs: Comparison of Revenues and Market Shares, 2019 and 2025
5.3 Which National Markets Will Grow Fastest to 2025?
5.4 The US: Dominating the Antithrombotic Drug Market Through 2014-2025
5.5 The EU5: Are the Guidelines for Approval of Biosimilar LMWHs Set to Change?
5.5.1 Germany Leads the EU5
5.5.2 France: Healthcare System Reform Will Inhibit Sales Growth?
5.5.3 UK: Pharmaceutical Price Regulation Scheme
5.5.4 Italy’s Healthcare System – Advantages Conducive to Business
5.5.5 Spain: Reductions in Governmental Healthcare Spending Will Restrict Growth
5.6 Japan: The Aging Population Will Stimulate Demand for Antithrombotic Drugs from 2015-2025
5.7 Chinese Antithrombotic Drug Market Will Capture Market Share
5.8 Brazilian Antithrombotic Drug Market 2015-2025: Strong Growth as Universal Healthcare Coverage is Expanded
5.9 Indian Antithrombotic Drug Market – Limited by Governmental Healthcare Spending?
5.10 Russian Antithrombotic Drug Market: Limited Healthcare Funding Will Prevent Expansive Growth

6. Antithrombotic Drug Development: R&D Pipeline
6.1 The R&D Pipeline for Antithrombotic Drugs: Overview
6.2 The Antiplatelet Drug R&D Pipeline in 2014
6.2.1 Pozen is Seeking a Strategic Partner for its Antiplatelet Drug, PA32540
6.2.2 The Medicines Company’s Kangrexel (Cangrelor) Awaits Approval
6.3 The R&D Pipeline for Anticoagulants, 2014
6.3.1 Heparins: Little R&D Activity in 2014
6.3.1.1 Will Development of Momenta’s Adomiparin Continue?
6.3.1.2 The Discontinuation of Semuloparin
6.3.2 The Vitamin K Antagonist Pipeline: One Product in Development in 2014
6.3.3 Many Development Direct Thrombin Inhibitors Have Been Discontinued
6.3.4 The Direct Factor Xa Inhibitor Pipeline: Only Two Compounds Remain
6.3.5 Portola Pharmaceuticals’ Betrixaban
6.3.6 Sanofi Has Apparently Discontinued Development of Otamixaban
6.4 The Fibrinolytics R&D Pipeline, 2014
6.4.1 Lundbeck’s Desmoteplase: Failed to Meet Primary Endpoint in Phase III
6.4.2 Bharat Biotech and ThromboGenics’ THR-100
6.5 The R&D Pipeline for Other Antithrombotic Drugs, 2014
6.5.1 Kyowa Hakko Kirin’s KW-3357: Filed in Japan, 2014
6.5.2 Asahi Kasei Pharma America’s ART 123
6.5.3 Regado Biosciences/Tobira Therapeutics is Developing an Anticoagulation System with an Antidote
6.5.4 Isis Pharmaceuticals’ ISIS-FXI Rx

7. Leading Companies in the Antithrombotic Drug Market
7.1 Leading Antithrombotic Drug Manufacturers in 2014
7.2 Sanofi Leads the Market, but is its Position Under Threat?
7.3 Boehringer Ingelheim Captures Market Share
7.4 Bayer Markets Two Antithrombotic Drugs
7.5 Johnson & Johnson Can Achieve Success with a Limited Product Portfolio
7.6 Genentech Will Retain Market Share
7.7 The Medicines Company’s Position Will be Bolstered by the Launch of its New Drug
7.8 Eli Lilly: Market Position is Dependent on Success of Effient
7.9 Otsuka: A Limited Antithrombotic Drug Portfolio
7.10 Pfizer: A Gradually Increasing Share of the Market
7.11 Bristol-Myers Squibb Had a Dramatic Loss of Market Share in 2013

8. Qualitative Analysis of the Antithrombotic Drugs Market, 2015
8.1 The Strengths and Weaknesses of the Antithrombotic Drug Market in 2015
8.1.1 Thrombotic Disease: Management Rather Than Cure
8.1.2 The Lack of Antidotes for the Novel Oral Anticoagulants Restricts the Market
8.2 Opportunities and Threats Facing the Market 2015-2025
8.2.1 Rising Disease Prevalence Creates Opportunities in the Market
8.2.2 Further Development of Existing Drugs
8.2.3 High Demand for Antidotes to the Novel Oral Anticoagulants
8.2.4 The Threat of Generic Competition
8.2.5 High Level of Competition is a Threat to New Entrants – What Can Developers Do?
8.2.6 High Risk of Investment in New Drug Development
8.2.7 Healthcare Budget Pressures Threaten Drug Launches and Prices in Europe
8.3 Social, Technological, Economic and Political Factors Influencing the Antithrombotic Drug Market 2015-2025
8.3.1 Social Factors: An Expanding Patient Population and Increasing Awareness
8.3.2 Technological Advances Encourage the Development of Improved Treatment Options
8.3.3 Economic Factors
8.3.3.1 Cost Cutting in the EU and the US
8.3.3.2 Free Trade within the EU Presents Challenges
8.3.4 Political Factors: Will the Affordable Care Act Increase Patient Access to Antithrombotic Drugs?

9. Research Interviews
9.1 Interview with Dr Sanjay Bhanot, PhD, Vice President of Clinical Development and Translational Medicine, Isis Pharmaceuticals, Inc.
9.1.1 Isis Pharmaceuticals Antithrombotic Drugs Pipeline
9.1.2 ISIS-FXIRx Phase II Results
9.1.3 Trends in the Antithrombotic Drug Market, 2015-2025
9.2 Interview with Dr Marcelo A. Lima, Research Fellow and Professor of Molecular Biology, Department of Biochemistry, Universidade Federal de São Paulo, Brazil
9.2.1 Recent Research on a Novel Heparin-Like Compound Derived From Shrimp
9.2.2 Heparin vs. Novel Oral Anticoagulants
9.2.3 Unmet Needs in Brazil and Worldwide
9.2.4 Trends in the Antithrombotic Drug Market

10. Conclusions from Our Study
10.1 The World Market for Antithrombotic Drugs 2015-2025
10.1.1 The Decline of Antiplatelet Drugs and the Rise of the Anticoagulants
10.2 The Leading National Markets 2015-2025
10.3 Trends in the Industry
10.3.1 The Market Will Recover From Plavix Decline
10.3.2 The Demand for Antithrombotic Drugs is Increasing Worldwide
10.3.3 Many Drugs Will Face Generic Competition Over the Coming 10 Years
10.3.4 High Barriers to Market Entry and a Limited Pipeline – The Implications


【レポート販売概要】

■ タイトル:抗血栓薬の世界市場:抗凝固薬、抗血小板薬
■ 英文:Antithrombotic Drugs: World Industry and Market Prospects 2015-2025
■ 発行日:2015年3月
■ 調査会社:visiongain
■ 商品コード:VGAIN5040808
■ 調査対象地域:グローバル
  • Perpetual Energy Inc.:石油・ガスの開発・生産動向及びコスト分析- Q4, 2012
    Perpetual Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2012 Summary Perpetual Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
  • Metastatic Uveal Melanoma:グローバル臨床試験レビュー(2014年上半期)
    Metastatic Uveal Melanoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Uveal Melanoma Global Clinical Trials Review, H1, 2014" provides data on the Metastatic Uveal Melanoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Uveal Melanoma. It includes an overview of the trial …
  • ソフトウエア定義データセンター(SDDC)の世界市場2019-2023
    Global Software-defined Data Center Market: About this market Enterprises have been deploying software-defined data center solutions to increase the efficiency, agility, flexibility, and scalability of data centers. Also, these solutions reduce the overall expense of enterprises by eliminating their dependency on hardware. Technavio’s software-defined data center market analysis considers sales fr …
  • 堅牢型ICの世界市場2018-2022
    About this market The global rugged IC market is growing due to increasing demand for ruggedized computers and embedded boards used in robots for mission- critical applications in the defense sector. Recent application areas wherein ruggedized computers are being used include logistics and cargo transportation, maintenance of vehicles and machinery and medical industry. Any rugged systems or solut …
  • 熱交換器の世界市場:シェル&チューブ、プレート&フレーム、空冷式、マイクロチャンネル
    The global heat exchangers market accounted for $16,624.0 million in 2018, and is anticipated to reach $29,316.0 million by 2026, registering a CAGR of 7.2% from 2019 to 2026. Heat exchangers are devices designed to transfer heat between two or more fluids and between a solid surface and fluids at different temperatures. Heat exchangers are highly labor-intensive to produce, which is attributed to …
  • コハク酸の世界市場予測(~2023年)
    “The succinic acid market is projected to register a CAGR of 6.8% between 2018 and 2023.”The global succinic acid market is estimated to be USD 132 million in 2018 and is projected to reach USD 183 million by 2023, at a CAGR of 6.8%. The increasing demand from the industrial, personal care and food & beverage industries fuels the succinic acid market. The increasing demand from the APAC region, an …
  • 防曇添加剤の世界市場:グリセロールエステル、ポリグリセロールエステル、ソルビタン脂肪酸エステル、エトキシル化ソルビタンエステル、オレイン酸ポリオキシエチレンエステル、ゼラチン、二酸化チタン
    The global antifog additives market is projected to reach USD 1.74 Billion by 2020, at a CAGR of 7.3% between 2015 and 2020. Rising demand for antifog additive films from the food packaging and agricultural sectors and the increasing demand for packed food items are major factors influencing the growth of this market. Among all applications, the food packaging films segment led the global antifog …
  • 女性用健康リハビリ製品の世界市場分析:製品別(整形外科ケア、尿失禁、乳がんケア、妊娠出産後ケア)、治療別(理学療法、作業療法)、セグメント予測、2014-2025
    The global women’s health rehabilitation products market is expected to reach USD 4.4 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth over the forecast period, owing to increasing prevalence of chronic diseases coupled with rising female geriatric population. Growing global population coupled with increasing birth rates is …
  • 世界のスピリッツ(蒸留酒)市場動向:企業M&A(2014年5月)
    Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global spirits market during May 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global spirits market throughout the month. Additionally, the report provides an overview of all the partnering, …
  • 産業用ドローン(無人機)の世界市場2016-2020
    About Commercial-purpose Drones Drones are UAVs. Their flight is controlled with a handheld remote or GPS remote. GPS is used to track the drones. The gyrometer and accelerometer, which are attached to the drones, are used to control the drones during flight. Drones are primarily used for tasks that are of high risk to human life. They are extensively used for surveillance and rescue, emergency re …
  • Liver Fibrosis:グローバル臨床試験レビューH2, 2013
    Liver Fibrosis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Liver Fibrosis Global Clinical Trials Review, H2, 2013" provides data on the Liver Fibrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Fibrosis. It includes an overview of the trial numbers and their recruitment status as per …
  • Bonavista Energy Corporation:石油・ガスバリューチェーン分析レポート2013
    Bonavista Energy Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Bonavista Energy Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Bonavista Energy Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the valu …
  • ハロゲンフリー難燃剤の世界市場2017-2021
    ABSTRACTAbout Halogen-Free Flame Retardant Chemicals Halogen-free flame retardant chemicals are components used to reduce the devastating impact of fire without emitting toxic gases that have adverse effects on people and the environment. The major end-user industries include building and construction, electrical and electronics, textile, transportation, and wires and cables. Halogen-free flame re …
  • モノクロル酢酸の世界市場2015-2019
    About MCAA MCAA, also called chloroacetic acid, is a bi-functional molecule-structured acid. It is extensively used as a chemical intermediate for the production of numerous industrially and commercially important chemicals, including glycine, CMC, TGA, and cyanoacetic acid. It is also used in the production of betaine-type surfactants, synthetic caffeine, and vitamins, and the production of 2,4-D …
  • アミノ酸の世界市場2016-2020
    About Amino Acid Amino acids are organic compounds made up of amines (NH2) and carboxylic acid (COOH) functional groups. They act as building blocks of proteins and as metabolic intermediates. Amino acids are the core of all biological processes, as they are crucial for every metabolic process. Additionally, they aid in the development, repair, and maintenance of body tissues. Even though the huma …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。